Advertisement
Research Article Free access | 10.1172/JCI105777
5th and 6th (Boston University) Medical Services, Boston City Hospital, Evans Memorial Department of Clinical Research, University Hospital, Department of Medicine and Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118
Department of Medicine, Children's Hospital Medical Center, Boston, Massachusetts 02118
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02118
Find articles by Cooperband, S. in: JCI | PubMed | Google Scholar
5th and 6th (Boston University) Medical Services, Boston City Hospital, Evans Memorial Department of Clinical Research, University Hospital, Department of Medicine and Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118
Department of Medicine, Children's Hospital Medical Center, Boston, Massachusetts 02118
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02118
Find articles by Rosen, F. in: JCI | PubMed | Google Scholar
5th and 6th (Boston University) Medical Services, Boston City Hospital, Evans Memorial Department of Clinical Research, University Hospital, Department of Medicine and Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118
Department of Medicine, Children's Hospital Medical Center, Boston, Massachusetts 02118
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02118
Find articles by Kibrick, S. in: JCI | PubMed | Google Scholar
Published April 1, 1968 - More info
Circulating lymphocytes from patients with congenital X-linked agammaglobulinemia, sporadic congenital agammaglobulinemia, and acquired agammaglobulinemia have been cultured in vitro. They have been shown to proliferate in a normal manner under stimulus of phytohemagglutinin and antigens to which the patient was sensitized. Agammaglobulinemic cells have been shown to synthesize protein at a rate similar to that of normal cells, and the character of the extracellular protein produced is also similar. Agammaglobulinemic lymphocytes have been found to produce a small quantity of immunoglobulin G, similar to that found in normal cell cultures. The quantity of immunoglobulin produced may be increased by exposure of the cells to phytohemagglutinin. From these data, it appears that the basic lesion responsible for agammaglobulinemia is not a deficiency in lymphocyte-mediated antigen recognition or cellular proliferation. It would also appear that the basic deficiency in these disorders does not involve the structural or regulatory genes necessary for the synthesis of immunoglobulins. By exclusion, the pathogenesis of the deficiency would appear to involve cells other than circulating lymphocytes.